This product is intended strictly for laboratory, analytical, and non-clinical research purposes only
After treatment discontinuation, milk levels decreased to 97 and 68 pmol/L (131 and 92 ng/L), respectively, at 3 months and 106 and 80 pmol/L (144 and 108 ng/L), respectively, at 6 months postpartum
Physical function improved significantly across all measures
Rare but Serious Side Effects While the majority of side effects are manageable, there are rare instances where medical attention is necessary
While their dosages may not be the same, both semaglutide and tirzepatide injections do follow a similar dosing schedule
You can use your Goals to Discharge Checklist to see the goals you need to meet before leaving the hospital